← FDA DRUG APPROVALS

FDA NDA · NDA005509

DICUMAROL

Sponsor: LILLY

APPLICATION
NDA005509
TYPE
NDA
LATEST ACTION
1977-08-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DICUMAROLDiscontinued
DICUMAROL 25MG · CAPSULE · ORAL
DICUMAROLDiscontinued
DICUMAROL 50MG · CAPSULE · ORAL

Approval history

1977-08-10Labeling · Supplement 5AP
1976-04-09Labeling · Supplement 4AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →